Arcoma AB/ SE0006219176 /
| 2024-04-24 12:00:00 AM | Chg. -0.25 | Volume | Bid5:29:56 PM | Ask5:29:56 PM | High | Low |
|---|---|---|---|---|---|---|
| 11.65SEK | -2.10% | 49,419 Turnover: 581,379.90 |
11.70Bid Size: - | 11.80Ask Size: - | 12.10 | 11.55 |
GlobeNewswire
2023-11-29
Valo Therapeutics Announces Regulatory Approval to Expand Phase I Immuno-oncology Trial into Sarcoma
GlobeNewswire
2020-11-04
Oncternal Announces Third Quarter 2020 Financial Results and Provides Business Update
GlobeNewswire
2020-10-14
Arvinas Announces Pipeline Programs Targeting Validated and Classically “Undruggable” Disease-Causin...
GlobeNewswire
2019-06-25
Global Operating Tables Market Forecasts to 2022: Growing Trend toward Hybrid Operating Rooms Spurs ...
GlobeNewswire
2017-05-10
TRACON Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
GlobeNewswire
2017-04-10
TRACON Awarded ‘Most Innovative Trial Design’ for Phase 3 TAPPAS Clinical Trial of TRC105 in Angiosa...
GlobeNewswire
2017-02-28
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2016 Financial Results and Provides Corp...
